Quest Diagnostics (DGX) Tops Q4 EPS by 2c, Offers Guidance

Go back to Quest Diagnostics (DGX) Tops Q4 EPS by 2c, Offers Guidance

Quest Diagnostics (DGX) PT Raised to $112 at Citi

February 5, 2018 5:15 AM EST

Citi raised its price target on Quest Diagnostics (NYSE: DGX) to $112.00 (from $98.00) while maintaining a Neutral rating.

... More

Credit Suisse Assumes Quest Diagnostics (DGX) at Neutral

February 2, 2018 7:28 AM EST

Credit Suisse assumes coverage on Quest Diagnostics (NYSE: DGX) with a Neutral rating and a price target of $107.00.

A.J. Rice is the new analyst covering the stock.

For an analyst ratings summary and ratings history on Quest Diagnostics... More

Quest Diagnostics (DGX) PT Raised to $110 at SunTrust Robinson Humphrey

February 2, 2018 2:48 AM EST

SunTrust Robinson Humphrey raised its price target on Quest Diagnostics (NYSE: DGX) to $110.00 (from $105.00) while maintaining a Hold rating.

Analyst David MacDonald likes the strong underlying trends alongside what he calls an "attractive opportunity."

... More

Quest Diagnostics (DGX) Raises Quarterly Dividend 11.1% to $0.50; 1.9% Yield

February 1, 2018 7:12 AM EST

Quest Diagnostics (NYSE: DGX) declared a quarterly dividend of $0.50 per share, or $2 annualized. This is an 11.1% increase from the prior dividend of $0.45.

The dividend will be payable on April 18, 2018, to stockholders of record on April 4, 2018, with an ex-dividend date of April 3,... More